Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Pharmacological profiles and clinical effects of oral sustained release beraprost sodium (Careload LA tablets 60 microg, Berasus LA tablets 60 microg)].

× No keyword cloud information.

4 in total

1. Effects of novel cathepsin K inhibitor ONO-5334 on bone resorption markers: a study of four sustained release formulations with different pharmacokinetic patterns.

Authors: Makoto Tanaka; Yoshitaka Hashimoto; Noboru Sekiya; Naoki Honda; Steve Deacon; Masanobu Yamamoto
Journal: J Bone Miner Metab Date: 2013-10-11 Impact factor: 2.626

2. A multinational phase IIb/III trial of beraprost sodium, an orally active prostacyclin analogue, in patients with primary glomerular disease or nephrosclerosis (CASSIOPEIR trial), rationale and study design.

Authors: Hidetomo Nakamoto; Toshiro Fujita; Hideki Origasa; Masanao Isono; Hajimu Kurumatani; Kiyonobu Okada; Hiroyuki Kanoh; Takashi Kiriyama; Shunsuke Yamada
Journal: BMC Nephrol Date: 2014-09-19 Impact factor: 2.388

3. Orally active prostacyclin analogue beraprost sodium in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled, phase II dose finding trial.

Authors: Akio Koyama; Toshiro Fujita; Fumitake Gejyo; Hideki Origasa; Masanao Isono; Hajimu Kurumatani; Kiyonobu Okada; Hiroyuki Kanoh; Takashi Kiriyama; Shunsuke Yamada
Journal: BMC Nephrol Date: 2015-10-16 Impact factor: 2.388

4. Prostacyclin analog beraprost sodium efficacy in primary glomerular disease or nephrosclerosis: Analysis of the Japanese subgroup in CASSIOPEIR study.

Authors: Hajimu Kurumatani; Kiyonobu Okada; Hideki Origasa; Toshiro Fujita; Masanao Isono; Hidetomo Nakamoto
Journal: Ther Apher Dial Date: 2021-02-21 Impact factor: 1.762

4 in total